{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:18:06Z","timestamp":1783696686186,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.nrleng.2026.502008","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:33:39Z","timestamp":1774683219000},"page":"502008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world healthcare resource utilisation for migraine: Analysis of an administrative database in Colombia"],"prefix":"10.1016","volume":"41","author":[{"given":"F.","family":"Sobrino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.","family":"Bedoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2026.502008_bib0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The International Classification of Headache Disorders, 3rd edition (beta version)","volume":"33","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrleng.2026.502008_bib0010","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","article-title":"Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Stovner","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrleng.2026.502008_bib0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1526-4610.2005.05024.x","article-title":"Prevalence of migraine in Latin America","volume":"45","author":"Morillo","year":"2005","journal-title":"Headache"},{"key":"10.1016\/j.nrleng.2026.502008_bib0020","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1001\/jama.2021.7939","article-title":"Acute treatments for episodic migraine in adults","volume":"325","author":"VanderPluym","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.nrleng.2026.502008_bib0025","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache Report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2026.502008_bib0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2026.502008_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111557","article-title":"Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine","volume":"139","author":"Khan","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nrleng.2026.502008_bib0040","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/0333102411398400","article-title":"Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review","volume":"31","author":"Lant\u00e9ri-Minet","year":"2010","journal-title":"Cephalalgia"},{"issue":"S1","key":"10.1016\/j.nrleng.2026.502008_bib0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/head.13301","article-title":"Migraine burden of disease: from the patient\u2019s experience to a socio\u2010economic view","volume":"58","author":"Agosti","year":"2018","journal-title":"Headache"},{"key":"10.1016\/j.nrleng.2026.502008_bib0050","article-title":"Estudio de la epidemiolog\u00eda neurol\u00f3gica en Colombia a partir de informaci\u00f3n administrativa (ESENCIA). Resultados preliminares 2015-2017","volume":"53","author":"Pinilla-Monsalve","year":"2021","journal-title":"Rev Univ Ind Santander Salud"},{"key":"10.1016\/j.nrleng.2026.502008_bib0055","first-page":"7","article-title":"The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future","volume":"1","author":"Omboni","year":"2022","journal-title":"Connect Heal"},{"key":"10.1016\/j.nrleng.2026.502008_bib0060","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/0333102414559735","article-title":"Gender influences headache characteristics with increasing age in migraine patients","volume":"35","author":"Bolay","year":"2014","journal-title":"Cephalalgia"},{"issue":"Suppl 1","key":"10.1016\/j.nrleng.2026.502008_bib0065","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/MLR.0000000000001812","article-title":"Impact of COVID-19 on trends in outpatient clinic utilization: a tale of 2 departments","volume":"61","author":"McCracken","year":"2023","journal-title":"M\u00e9d Care"},{"key":"10.1016\/j.nrleng.2026.502008_bib0070","author":"Mehrotra"},{"key":"10.1016\/j.nrleng.2026.502008_bib0075","series-title":"Cifras de aseguramiento en salud","year":"2021"},{"key":"10.1016\/j.nrleng.2026.502008_bib0080","series-title":"La salud en Colombia: m\u00e1s cobertura pero menos acceso. Documentos de Trabajo Sobre Econom\u00eda Regional","author":"Ayala Garc\u00eda","year":"2014"},{"key":"10.1016\/j.nrleng.2026.502008_bib0085","doi-asserted-by":"crossref","DOI":"10.1177\/03331024221128265","article-title":"Primary headache disorders in Latin America and the Caribbean: a meta-analysis of population-based studies","volume":"43","author":"Pacheco-Barrios","year":"2023","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrleng.2026.502008_bib0090","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/head.13421","article-title":"Health care resource utilization and migraine disability along the migraine continuum among patients treated for migraine","volume":"58","author":"Silberstein","year":"2018","journal-title":"Headache"},{"key":"10.1016\/j.nrleng.2026.502008_bib0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s10194-024-01918-9","article-title":"Epidemiological, clinical characterization and treatment patterns of migraine patients in a Colombian cohort from 2018 to 2022","volume":"25","author":"Rubio","year":"2024","journal-title":"J Headache Pain"},{"issue":"0","key":"10.1016\/j.nrleng.2026.502008_bib0100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2147\/PPA.S346660","article-title":"Treatment patterns for calcitonin gene-related peptide monoclonal antibodies including galcanezumab versus conventional preventive treatments for migraine: a retrospective US claims study","volume":"16","author":"Varnado","year":"2022","journal-title":"Patient Prefer Adherence"},{"issue":"Suppl 2","key":"10.1016\/j.nrleng.2026.502008_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-2982.2008.01684.x","article-title":"The role of general practitioners in migraine management","volume":"28","author":"Lant\u00e9ri\u2010Minet","year":"2008","journal-title":"Cephalalgia"},{"issue":"Suppl 1","key":"10.1016\/j.nrleng.2026.502008_bib0110","first-page":"18","article-title":"Initiating and optimizing acute therapy for migraine: the role of patient-centered stratified care","volume":"118","author":"Diamond","year":"2005","journal-title":"Am J Med Suppl"},{"key":"10.1016\/j.nrleng.2026.502008_bib0115","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/head.12755","article-title":"Direct and indirect costs of chronic and episodic migraine in the United States: a web\u2010based survey","volume":"56","author":"Messali","year":"2016","journal-title":"Headache"},{"key":"10.1016\/j.nrleng.2026.502008_bib0120","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.puhe.2005.01.009","article-title":"Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico","volume":"119","author":"Arredondo","year":"2005","journal-title":"Public Heal"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580826000532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580826000532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:03:57Z","timestamp":1783695837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580826000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2173580826000532"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2026.502008","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world healthcare resource utilisation for migraine: Analysis of an administrative database in Colombia","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2026.502008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2025.502008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Neurolog\u00eda.","name":"copyright","label":"Copyright"}],"article-number":"502008"}}